X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-12-10 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | CEO | S - Sale | $3.31 | -4,155 | 763,926 | -1% | -$13,753 | ||||||
2025-12-10 | SERA | Sera Prognostics, Inc. | Kearney Paul | Chief Data Officer | S - Sale | $3.31 | -1,213 | 167,383 | -1% | -$4,015 | ||||||
2025-12-10 | SERA | Sera Prognostics, Inc. | Jackson Benjamin | GC | S - Sale | $3.31 | -892 | 118,866 | -1% | -$2,953 | ||||||
2025-12-10 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $3.31 | -616 | 86,788 | -1% | -$2,039 | ||||||
2025-12-10 | SERA | Sera Prognostics, Inc. | Boniface John J. | Chief Scientific Officer | S - Sale | $3.31 | -1,332 | 150,397 | -1% | -$4,409 | ||||||
2025-12-10 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $3.31 | -873 | 272,214 | 0% | -$2,890 | ||||||
2025-12-08 | GH | Guardant Health, Inc. | Talasaz Amirali | Co-CEO | S - Sale | $105.06 | -100,000 | 419,300 | -19% | -$10,505,474 | ||||||
2025-12-08 | GH | Guardant Health, Inc. | Kalia Kumud | CIO | S - Sale | $104.60 | -2,000 | 22,365 | -8% | -$209,204 | ||||||
| D | 2025-12-08 | GH | Guardant Health, Inc. | Hidalgo Medina Manuel | Dir | S - Sale+OE | $105.00 | -1,250 | 797 | -61% | -$131,250 | |||||
2025-12-08 | GH | Guardant Health, Inc. | Chudova Darya | CTO | S - Sale | $105.43 | -22,935 | 66,943 | -26% | -$2,417,980 | ||||||
2025-12-09 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | CEO | S - Sale | $3.04 | -28,215 | 768,081 | -4% | -$85,774 | ||||||
2025-12-09 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $3.04 | -5,232 | 273,087 | -2% | -$15,905 | ||||||
| D | 2025-12-05 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | S - Sale+OE | $243.10 | -4,366 | 5,777 | -43% | -$1,061,389 | |||||
| D | 2025-12-05 | CELC | Celcuity Inc. | Buller Richard E | Dir | S - Sale+OE | $105.69 | -3,000 | 7,789 | -28% | -$317,070 | |||||
2025-12-05 | RDNT | Radnet, Inc. | Forthuber Stephen M | Pres, COO-Eastern Operations | S - Sale | $78.33 | -45,088 | 529,221 | -8% | -$3,531,849 | ||||||
2025-12-05 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Officer | S - Sale | $103.07 | -31,452 | 25,987 | -55% | -$3,241,621 | ||||||
| D | 2025-12-05 | GH | Guardant Health, Inc. | Bell Michael Brian | CFO | S - Sale+OE | $103.14 | -80,362 | 28,052 | -74% | -$8,288,742 | |||||
| D | 2025-12-05 | GH | Guardant Health, Inc. | Clark Ian T | Dir | S - Sale+OE | $107.19 | -28,611 | 9,851 | -74% | -$3,066,817 | |||||
2025-12-08 | SERA | Sera Prognostics, Inc. | Lawrence Sandra Aj | Dir | S - Sale | $3.05 | -1,560 | 19,593 | -7% | -$4,758 | ||||||
| D | 2025-12-05 | VCYT | Veracyte, Inc. | Eastham Karin | Dir | S - Sale+OE | $45.45 | -20,000 | 13,554 | -60% | -$908,923 | |||||
2025-12-04 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $40.03 | -1,339 | 298,919 | 0% | -$53,600 | ||||||
2025-12-05 | SERA | Sera Prognostics, Inc. | Mirza Mansoor Raza | Dir | S - Sale | $3.05 | -292 | 57,740 | -1% | -$891 | ||||||
2025-12-03 | GRAL | Grail, Inc. | Ofman Joshua J. | Pres | S - Sale | $100.00 | -13,000 | 368,818 | -3% | -$1,300,000 | ||||||
2025-12-03 | GRAL | Grail, Inc. | Ragusa Robert P | CEO | S - Sale | $95.24 | -40,000 | 688,029 | -5% | -$3,809,535 | ||||||
2025-12-03 | GRAL | Grail, Inc. | Freidin Aaron | CFO | S - Sale | $99.15 | -25,000 | 259,077 | -9% | -$2,478,818 | ||||||
2025-12-04 | CDNA | Caredx, Inc. | Novack Jeffrey Adam | Secretary, GC | S - Sale | $19.17 | -7,293 | 97,925 | -7% | -$139,804 | ||||||
2025-12-04 | VCYT | Veracyte, Inc. | McGuire Annie | SVP, GC | S - Sale | $47.30 | -1,422 | 78,499 | -2% | -$67,261 | ||||||
2025-12-04 | VCYT | Veracyte, Inc. | Chambers Rebecca | CFO | S - Sale | $46.84 | -13,278 | 109,496 | -11% | -$621,955 | ||||||
2025-12-04 | VCYT | Veracyte, Inc. | Stapley Marc | CEO | S - Sale | $47.09 | -7,668 | 318,603 | -2% | -$361,076 | ||||||
2025-12-04 | VCYT | Veracyte, Inc. | Leite John | Chief Commercial Officer-CLIA | S - Sale | $47.51 | -1,278 | 82,113 | -2% | -$60,718 | ||||||
2025-12-02 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $39.23 | -2,678 | 300,258 | -1% | -$105,058 | ||||||
| D | 2025-12-01 | GH | Guardant Health, Inc. | Monroe Terilyn J. | Chief People Officer | S - Sale+OE | $105.97 | -55,167 | 20,920 | -73% | -$5,846,163 | |||||
2025-12-01 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $238.15 | -3,000 | 109,061 | -3% | -$714,459 | ||||||
2025-12-01 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $238.07 | -4,400 | 140,416 | -3% | -$1,047,502 | ||||||
2025-12-02 | FLGT | Fulgent Genetics, Inc. | Xie Jian | Pres, COO | S - Sale | $28.33 | -1,140 | 557,565 | 0% | -$32,298 | ||||||
2025-12-02 | FLGT | Fulgent Genetics, Inc. | Gao Hanlin | Chief Scientific Officer | S - Sale | $28.33 | -1,075 | 952,890 | 0% | -$30,457 | ||||||
2025-12-02 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $2.93 | -2,000 | 87,404 | -2% | -$5,860 | ||||||
| D | 2025-12-02 | SERA | Sera Prognostics, Inc. | Kearney Paul | Chief Data Officer | S - Sale+OE | $2.94 | -32,203 | 168,596 | -16% | -$94,677 | |||||
| D | 2025-12-01 | CELC | Celcuity Inc. | Buller Richard E | Dir | S - Sale+OE | $98.13 | -1,100 | 7,789 | -12% | -$107,948 | |||||
2025-11-28 | FLGT | Fulgent Genetics, Inc. | Xie Jian | Pres, COO | S - Sale | $29.57 | -1,198 | 558,705 | 0% | -$35,424 | ||||||
2025-11-28 | FLGT | Fulgent Genetics, Inc. | Gao Hanlin | Chief Scientific Officer | S - Sale | $29.57 | -943 | 953,965 | 0% | -$27,884 | ||||||
2025-11-26 | ACON | Aclarion, Inc. | Ness Brent | CEO | P - Purchase | $6.20 | +10 | 11 | >999% | +$62 | ||||||
2025-11-26 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $40.09 | -4,258 | 302,936 | -1% | -$170,703 | ||||||
| D | 2025-11-25 | PSNL | Personalis, Inc. | Tachibana Aaron | CFO, COO | S - Sale+OE | $10.78 | -103,668 | 164,458 | -39% | -$1,117,541 | |||||
| D | 2025-11-25 | DGX | Quest Diagnostics Inc | Davis J. E. | CEO, Pres | S - Sale+OE | $192.22 | -55,093 | 120,480 | -31% | -$10,589,760 | |||||
2025-11-25 | DGX | Quest Diagnostics Inc | Gregg Vicky B | Dir | S - Sale | $191.76 | -1,250 | 17,037 | -7% | -$239,700 | ||||||
| D | 2025-11-26 | SERA | Sera Prognostics, Inc. | Kearney Paul | Chief Data Officer | S - Sale+OE | $3.51 | -1,986 | 168,596 | -1% | -$6,971 | |||||
2025-11-24 | NTRA | Natera, Inc. | Botha Roelof | Dir | S - Sale | $236.12 | -75,000 | 1,156,626 | -6% | -$17,708,936 | ||||||
2025-11-25 | VCYT | Veracyte, Inc. | Leite John | Chief Commercial Officer-CLIA | S - Sale | $50.00 | -2,808 | 86,291 | -3% | -$140,400 | ||||||
2025-11-25 | VCYT | Veracyte, Inc. | Jones Evan/ Fa | Dir | S - Sale | $50.25 | -1,106 | 29,362 | -4% | -$55,576 | ||||||
2025-11-25 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $40.05 | -5,115 | 307,194 | -2% | -$204,851 | ||||||
2025-11-24 | FLGT | Fulgent Genetics, Inc. | Xie Jian | Pres, COO | S - Sale | $30.47 | -681 | 559,903 | 0% | -$20,752 | ||||||
2025-11-24 | FLGT | Fulgent Genetics, Inc. | Gao Hanlin | Chief Scientific Officer | S - Sale | $30.47 | -535 | 954,908 | 0% | -$16,303 | ||||||
| D | 2025-11-20 | CSTL | Castle Biosciences Inc | Juvenal Tobin W | Chief Commercial Officer | S - Sale+OE | $35.58 | -4,693 | 86,825 | -5% | -$166,977 | |||||
2025-11-21 | CELC | Celcuity Inc. | Dalvey David | Dir | S - Sale | $100.00 | -15,000 | 110,000 | -12% | -$1,500,017 | ||||||
| M | 2025-11-20 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $226.49 | -14,000 | 269,224 | -5% | -$3,170,846 | |||||
| DM | 2025-11-19 | NTRA | Natera, Inc. | Baynes Roy D. | Dir | S - Sale+OE | $219.85 | -12,780 | 18,359 | -41% | -$2,809,689 | |||||
2025-11-19 | EXAS | Exact Sciences Corp | Orville Jacob A | EVP, GM, Screening | S - Sale | $75.00 | -5,000 | 24,727 | -17% | -$375,000 | ||||||
2025-11-19 | EXAS | Exact Sciences Corp | Herriott James | SVP, GC, Sec | S - Sale | $70.00 | -1,000 | 13,141 | -7% | -$70,000 | ||||||
2025-11-19 | FLGT | Fulgent Genetics, Inc. | Xie Jian | Pres, COO | S - Sale | $29.10 | -10,000 | 560,584 | -2% | -$290,983 | ||||||
2025-11-20 | VCYT | Veracyte, Inc. | Holstein Jens | Dir | S - Sale | $42.36 | -10,000 | 27,199 | -27% | -$423,563 | ||||||
| D | 2025-11-20 | CELC | Celcuity Inc. | Buller Richard E | Dir | S - Sale+OE | $96.73 | -3,900 | 8,289 | -32% | -$377,255 | |||||
2025-11-19 | GH | Guardant Health, Inc. | Tariq Musa | Dir | S - Sale | $96.25 | -116 | 7,859 | -1% | -$11,165 | ||||||
| D | 2025-11-18 | DGX | Quest Diagnostics Inc | Delaney Mark E | SVP, Chief Commercial Officer | S - Sale+OE | $187.35 | -7,946 | 7,530 | -51% | -$1,488,683 | |||||
2025-11-18 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $34.02 | -2,678 | 312,309 | -1% | -$91,106 | ||||||
| M | 2025-11-17 | RDNT | Radnet, Inc. | Patel Mital | EVP of Fin Planning, CAO | S - Sale | $78.05 | -50,000 | 180,138 | -22% | -$3,902,254 | |||||
2025-11-17 | GRAL | Grail, Inc. | Freidin Aaron | CFO | S - Sale | $79.20 | -1,697 | 284,077 | -1% | -$134,402 | ||||||
| ADM | 2025-11-11 | CSTL | Castle Biosciences Inc | Juvenal Tobin W | Chief Commercial Officer | S - Sale+OE | $35.39 | -700 | 86,757 | -1% | -$24,775 | |||||
| D | 2025-11-10 | BDSX | Biodesix Inc | Vazquez Chris | Chief Accounting Officer | S - Sale+OE | $7.62 | -13 | 936 | -1% | -$99 | |||||
| D | 2025-11-10 | BDSX | Biodesix Inc | Pestano Gary Anthony | Chief Development Officer | S - Sale+OE | $7.62 | -23 | 7,939 | 0% | -$175 | |||||
| D | 2025-11-10 | BDSX | Biodesix Inc | O'Kane Kieran | Chief Commercial Officer | S - Sale+OE | $7.62 | -25 | 7,362 | 0% | -$191 | |||||
| D | 2025-11-10 | BDSX | Biodesix Inc | Hutton Scott | Pres, CEO | S - Sale+OE | $7.62 | -189 | 37,311 | -1% | -$1,440 | |||||
| D | 2025-11-10 | BDSX | Biodesix Inc | Cowie Robin Harper | CFO, Sec'y, Treasurer | S - Sale+OE | $7.62 | -50 | 13,147 | 0% | -$381 | |||||
2025-11-11 | CSTL | Castle Biosciences Inc | Stokes Frank | CFO | S - Sale | $35.08 | -5,388 | 43,328 | -11% | -$189,011 | ||||||
| M | 2025-11-11 | CSTL | Castle Biosciences Inc | Juvenal Tobin W | Chief Commercial Officer | S - Sale | $35.39 | -700 | 86,057 | -1% | -$24,775 | |||||
2025-11-11 | CSTL | Castle Biosciences Inc | Oelschlager Kristen M | COO | S - Sale | $35.10 | -18,932 | 109,574 | -15% | -$664,513 | ||||||
2025-11-11 | LH | Labcorp Holdings Inc. | Schechter Adam H | Pres, CEO | S - Sale | $262.75 | -5,745 | 87,574 | -6% | -$1,509,499 | ||||||
| M | 2025-11-07 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $197.61 | -4,570 | 283,224 | -2% | -$903,093 | |||||
| D | 2025-11-07 | BLLN | Billiontoone, Inc. | Lynch Thomas P. | See Remarks | P - Purchase | $60.00 | +100 | 700 | +17% | +$6,000 | |||||
| D | 2025-11-07 | BLLN | Billiontoone, Inc. | Tsao David | CTO | P - Purchase | $60.00 | +1,000 | 1,000 | New | +$60,000 | |||||
| D | 2025-11-07 | BLLN | Billiontoone, Inc. | Ten Bosch John Roderick | See Remarks | P - Purchase | $60.00 | +800 | 37,800 | +2% | +$48,000 | |||||
| D | 2025-11-07 | BLLN | Billiontoone, Inc. | Johnson Nancy Joann | See Remarks | P - Purchase | $60.00 | +6,900 | 35,900 | +24% | +$414,000 | |||||
2025-11-07 | BLLN | Billiontoone, Inc. | Rai Akshay | Dir | P - Purchase | $60.00 | +2,500 | 1,797,923 | 0% | +$150,000 | ||||||
| M | 2025-11-07 | VCYT | Veracyte, Inc. | Wygant Jonathan | VP, Chief Accounting Officer | S - Sale | $41.20 | -10,920 | 38,745 | -22% | -$449,907 | |||||
2025-11-10 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | CEO | S - Sale | $2.62 | -11,594 | 796,296 | -1% | -$30,376 | ||||||
2025-11-10 | SERA | Sera Prognostics, Inc. | Kearney Paul | Chief Data Officer | S - Sale | $2.62 | -7,073 | 168,596 | -4% | -$18,531 | ||||||
2025-11-10 | SERA | Sera Prognostics, Inc. | Jackson Benjamin | GC | S - Sale | $2.62 | -7,059 | 119,758 | -6% | -$18,495 | ||||||
2025-11-10 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $2.62 | -6,528 | 89,404 | -7% | -$17,103 | ||||||
2025-11-10 | SERA | Sera Prognostics, Inc. | Boniface John J. | Chief Scientific Officer | S - Sale | $2.62 | -7,767 | 151,726 | -5% | -$20,350 | ||||||
2025-11-10 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $2.62 | -6,351 | 278,319 | -2% | -$16,640 | ||||||
| D | 2025-11-07 | BLLN | Billiontoone, Inc. | Bremner Thomas S | Dir | P - Purchase | $60.00 | +41,666 | 701,476 | +6% | +$2,499,960 | |||||
| D | 2025-11-07 | GH | Guardant Health, Inc. | Hidalgo Medina Manuel | Dir | S - Sale+OE | $95.19 | -1,500 | 815 | -65% | -$142,780 | |||||
2025-11-07 | GH | Guardant Health, Inc. | Saia John G. | GC | S - Sale | $96.25 | -8,996 | 43,172 | -17% | -$865,865 | ||||||
2025-11-07 | CDNA | Caredx, Inc. | Novack Jeffrey Adam | Secretary, GC | S - Sale | $15.52 | -2,688 | 105,218 | -2% | -$41,723 | ||||||
2025-11-07 | CAI | Caris Life Sciences, Inc. | Denton John Russel | See Remarks | P - Purchase | $24.09 | +4,184 | 132,775 | +3% | +$100,793 | ||||||
2025-11-07 | CAI | Caris Life Sciences, Inc. | Spetzler David Baxley | Pres | P - Purchase | $23.85 | +400 | 460,777 | 0% | +$9,540 | ||||||
2025-11-05 | VCYT | Veracyte, Inc. | McGuire Annie | SVP, GC | S - Sale | $40.00 | -6,466 | 82,973 | -7% | -$258,640 | ||||||
| D | 2025-11-05 | VCYT | Veracyte, Inc. | Jones Evan/ Fa | Dir | S - Sale+OE | $45.06 | -43,196 | 30,468 | -59% | -$1,946,288 | |||||
2025-11-05 | VCYT | Veracyte, Inc. | Eastham Karin | Dir | S - Sale | $40.02 | -9,674 | 13,554 | -42% | -$387,191 | ||||||
2025-11-05 | VCYT | Veracyte, Inc. | Chambers Rebecca | CFO | S - Sale | $41.00 | -7,000 | 126,158 | -5% | -$287,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |